We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Prototype Kit Diagnoses Visceral Leishmaniasis

By LabMedica International staff writers
Posted on 07 May 2013
Print article
Image: Leishmania amastigotes (Photo courtesy of the US Centers for Disease Control and Prevention).
Image: Leishmania amastigotes (Photo courtesy of the US Centers for Disease Control and Prevention).
Image: Direct Agglutination Test (Photo courtesy of the Royal Tropical Institute).
Image: Direct Agglutination Test (Photo courtesy of the Royal Tropical Institute).
A prototype direct agglutination test (DAT) kit for the laboratory diagnosis of visceral leishmaniasis (VL), called DAT-LPC, has been developed.

The diagnosis validity of this prototype DAT-LPC, which uses a freeze-dried antigen, was performed to evaluate the sensitivity and specificity of the assay.

Scientists at the Oswaldo Cruz Foundation (FIOCRUZ; Belo Horizonte, Brazil) took blood samples from 103 Brazilian patients with VL and 110 samples from patients with other parasitic infections, and healthy subjects. These samples were assayed with DAT-LPC and DAT-KIT (Royal Tropical Institute; Amsterdam, NL). Additionally, the results of 103 samples of VL patients based on two agglutination tests were correlated.

The DAT-LPC was incubated for four hours at room temperature; the end titer was read as the dilution immediately before the well with a clear sharp-edged blue spot identical in size to the reaction negative control. Appropriate negative and positive control samples with known DAT titers were included. The cut-off for interpretation of positive and negative results was 1:100. The DAT-LPC showed a sensitivity of 99.0%, specificity of 98.2% and diagnosis validity of 98.6%, which were similar to those found by the DAT-KIT. Moreover, there was positive correlation between the positive titers obtained by DAT-LPC and by DAT-KIT.

After six months of storage in an incubator at 40 °C and 75% moisture the DAT-LPC prototype remained stable. Physical aspects remained the same, and it produced consistent results with negative and positive samples assayed monthly. The authors concluded that the prototype kit showed high diagnostic accuracy and thermal stability; it is ready for use and could be transferred to industrial production. The DAT-LPC should replace the indirect immunofluorescent antibody test (IFAT) in routine serological tests for VL diagnosis in Brazil. It could be used in a complementary algorithm with immunochromatic dipstick tests, for different clinical scenarios and laboratorial settings. The study was published on February 3, 2013, in the journal Transactions of The Royal Society of Tropical Medicine and Hygiene.

Related Links:

Oswaldo Cruz Foundation
Royal Tropical Institute


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Silver Member
Oncology Molecular Diagnostic Test
BCR-ABL Dx ELITe MGB Kit
New
Anti-Secukinumab ELISA
LISA-TRACKER anti-Secukinumab

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.